Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus.

Lawrence, Jody; Mayers, Douglas L; Hullsiek, Katherine Huppler; Collins, Gary; Abrams, Donald I; Reisler, Ronald B; Crane, Lawrence R; Schmetter, Barry S; Dionne, Thomas J; Saldanha, Jennifer M; Jones, Michael C; Baxter, John D

Lawrence, Jody; Mayers, Douglas L; Hullsiek, Katherine Huppler; Collins, Gary; Abrams, Donald I; Reisler, Ronald B; Crane, Lawrence R; Schmetter, Barry S; Dionne, Thomas J; Saldanha, Jennifer M; Jones, Michael C; Baxter, John D.

Affiliation

Lawrence J; Department of Medicine, Positive Health Program, San Francisco General Hospital, University of California, San Francisco, San Francisco, CA 94110, USA. jlawrence@php.ucsf.edu

N Engl J Med ; 349(9): 837-46, 2003 Aug 28.

Article in En | MEDLINE | ID: mdl-12944569

Subject(s)

Anti-HIV Agents/administration & dosage; HIV Infections/drug therapy; AIDS-Related Opportunistic Infections/epidemiology; Adult; CD4 Lymphocyte Count; Disease Progression; Drug Administration Schedule; Drug Resistance, Multiple, Viral; Female; HIV/drug effects; HIV/genetics; HIV/isolation & purification; HIV Infections/mortality; Humans; Male; Middle Aged; Multivariate Analysis; RNA, Viral/blood

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 2_ODS3 / 4_TD Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents Type of study: Clinical_trials Aspects: Patient_preference Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: N Engl J Med Year: 2003 Document type: Article

Search on Google

XML

PubMed Links